Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

LabPON Adopts Proscia’s Concentriq to Meet Demand for Diagnostic Services Amid Rising Cancer Burden

Proscia
By Author Proscia | January 11, 2021

Laboratorium Pathologie Oost-Nederland (LabPON), the first laboratory in the world to reach 100% digital pathology diagnosis, will deploy Proscia’s Concentriq platform. In transitioning to Concentriq, LabPON gains added flexibility to scale its routine digital pathology operations as the total number of worldwide cancer cases continues to rise. This includes establishing the software infrastructure for later implementing computational applications leveraging artificial intelligence to further improve diagnostic quality and efficiency.

Our website uses cookies. By using this site, you agree to its use of cookies.